AGP Picks
View all

Technology Review Mississippi
Provided by AGP

Technology Review Mississippi: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Review Mississippi.

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

Press releases published on August 6, 2026

Acorn’s Q2 EPS of $0.12 Reflects Increasing High-Margin, Recurring Monitoring Revenue; Growth Initiatives Include New Generator Partnership and OMNI360 Launch
Aug. 6, 2026

Acorn’s Q2 EPS of $0.12 Reflects Increasing High-Margin, Recurring Monitoring Revenue; Growth Initiatives Include New Generator Partnership and OMNI360 Launch

Indeterminate GlobeNewswire
argenx Announces Commencement of Tender Offer to Acquire Forte Biosciences, Inc.
Aug. 6, 2026

argenx Announces Commencement of Tender Offer to Acquire Forte Biosciences, Inc.

Indeterminate GlobeNewswire
Collegium Reports Second Quarter 2026 Financial Results and Highlights Recent Company Progress
Aug. 6, 2026

Collegium Reports Second Quarter 2026 Financial Results and Highlights Recent Company Progress

Indeterminate GlobeNewswire
Abeona Therapeutics® to Host Second Quarter 2026 Financial Results Conference Call on August 13, 2026
Aug. 6, 2026

Abeona Therapeutics® to Host Second Quarter 2026 Financial Results Conference Call on August 13, 2026

Indeterminate GlobeNewswire
BioVie Announces Topline Results of Phase 2 SUNRISE-PD Trial of Bezisterim in Early Parkinson’s Disease
Aug. 6, 2026

BioVie Announces Topline Results of Phase 2 SUNRISE-PD Trial of Bezisterim in Early Parkinson’s Disease

Indeterminate GlobeNewswire
Cronos Group Reports 2026 Second Quarter Results
Aug. 6, 2026

Cronos Group Reports 2026 Second Quarter Results

Indeterminate GlobeNewswire
Lexicon Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Clinical Updates 
Aug. 6, 2026

Lexicon Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Clinical Updates 

Indeterminate GlobeNewswire
Cerenome Selects XiFin Empower RCM for Revenue Cycle Management and Clearinghouse Services for CNSide Platform
Aug. 6, 2026

Cerenome Selects XiFin Empower RCM for Revenue Cycle Management and Clearinghouse Services for CNSide Platform

Indeterminate GlobeNewswire
ZenaTech Closes 27th Drone as a Service Acquisition Expanding into Idaho, Strengthening Drone-Based Surveying and Civil Engineering Services for Government and Construction Customers
Aug. 6, 2026

ZenaTech Closes 27th Drone as a Service Acquisition Expanding into Idaho, Strengthening Drone-Based Surveying and Civil Engineering Services for Government and Construction Customers

Indeterminate GlobeNewswire
InflaRx Reports Second Quarter 2026 Results and Highlights Key Achievements and Expected Milestones
Aug. 6, 2026

InflaRx Reports Second Quarter 2026 Results and Highlights Key Achievements and Expected Milestones

Indeterminate GlobeNewswire
Parker Reports Record Fiscal 2026 Fourth Quarter and Full Year Results
Aug. 6, 2026

Parker Reports Record Fiscal 2026 Fourth Quarter and Full Year Results

Indeterminate GlobeNewswire
Martin Eade and Natalie Southgate Launch Still Not Dead Podcast, Reaching the Top 10% of New Podcasts Globally Within Its First Week
Aug. 6, 2026

Martin Eade and Natalie Southgate Launch Still Not Dead Podcast, Reaching the Top 10% of New Podcasts Globally Within Its First Week

Indeterminate GlobeNewswire
Alterity Therapeutics to Present at the 46th Annual Canaccord Genuity Growth Conference
Aug. 6, 2026

Alterity Therapeutics to Present at the 46th Annual Canaccord Genuity Growth Conference

Indeterminate GlobeNewswire
Tarsus Reports Second Quarter 2026 Financial Results, Advances Next Phase of Growth
Aug. 6, 2026

Tarsus Reports Second Quarter 2026 Financial Results, Advances Next Phase of Growth

Indeterminate GlobeNewswire
Ocugen Provides Business Update with Second Quarter 2026 Financial Results
Aug. 6, 2026

Ocugen Provides Business Update with Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire
Tarsus Pharmaceuticals Announces Oversubscribed $125.0 Million Private Placement Equity Financing
Aug. 6, 2026

Tarsus Pharmaceuticals Announces Oversubscribed $125.0 Million Private Placement Equity Financing

Indeterminate GlobeNewswire
Iovance Biotherapeutics Reports Record Second Quarter 2026 Revenue of ~$99M, Business Achievements, and Corporate Updates
Aug. 6, 2026

Iovance Biotherapeutics Reports Record Second Quarter 2026 Revenue of ~$99M, Business Achievements, and Corporate Updates

Indeterminate GlobeNewswire
Tarsus Pharmaceuticals to Acquire Alkeus Pharmaceuticals and Advance Eye Care Leadership Position
Aug. 6, 2026

Tarsus Pharmaceuticals to Acquire Alkeus Pharmaceuticals and Advance Eye Care Leadership Position

Indeterminate GlobeNewswire
Immunocore reports second quarter financial results and provides a business update
Aug. 6, 2026

Immunocore reports second quarter financial results and provides a business update

Indeterminate GlobeNewswire
Power Apps Project Stalled or Abandoned: What Actually Fixes It
Aug. 6, 2026

Power Apps Project Stalled or Abandoned: What Actually Fixes It

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Technology Review Mississippi

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.